Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 18 clinical trials
Safety, Tolerability and Immunogenicity of INO-4700 for MERS-CoV in Healthy Volunteers

) injection followed by electroporation (EP) using the CELLECTRA™ 2000 device in healthy adult volunteers for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. This study is divided into 2

Accepts healthy volunteers
  • 7 views
  • 30 Jun, 2022
  • 6 locations
Prevalence of Long-term Respiratory Complications of Severe SARS-CoV-2 Pneumonia - COVID-19

Studies performed after coronavirus epidemics (severe acute respiratory syndrome coronavirus, SARS-CoV and Middle East respiratory syndrome coronavirus, MERS-CoV) have shown a long-term impact

  • 0 views
  • 28 Jan, 2021
  • 1 location
Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS

known as SARSCoV- 2 and the disease it causes COVID-19. Previous CoV epidemics included severe acute respiratory syndrome (SARS)-CoV, which started in China in 2003 and Middle East respiratory syndrome

coronavirus
covid-19
SARS
acute respiratory distress
pneumonia
  • 0 views
  • 30 Jun, 2022
  • 2 locations
Immunomodulatory Profile of Dexmedetomidine Sedation in Patients Recovering After ARDS Covid-19

Covid-19 infection is due to SARS-CoV-2 member of the Coronavirus family represented by SARSand MERS-CoVwith neuronal tropism capacity for the brainstem and thalami. Dexmedetomidine has(i) central antihypertensive (ii) sedative and (iii) neuroprotective properties and is often used during patient recovering after mechanical ventilation withdrawal. Dexmedetomidine administration could change the immunomodulatory …

middle east respiratory syndrome
respiratory distress
SARS
coronavirus infection
mechanical ventilation
  • 30 views
  • 27 Jun, 2021
  • 1 location
COVID-19 Pneumonitis Low Dose Lung Radiotherapy (COLOR-19)

Low-dose radiotherapy treatment delivered to both lungs in patients with immune-related pneumonia following COVID-19 infection is backed up by biological and clinical bases that justify its use as a possible therapeutic option in these patients. This is a preliminary exploratory study (non-pharmacological interventional) to evaluate the feasibility and tolerability of …

chest ct
covid-19
chest x-ray
SARS
pneumonia
  • 0 views
  • 25 Jan, 2021
  • 1 location
Immunogenetics Predictors With COVID-19

Background: There is a current worldwide outbreak of the novel coronavirus Covid-19 which originated from Wuhan in China and has now spread to 6 continents including 210 countries. There is still a lack of any report about severe acute respiratory syndromes (SARS-CoV-2) genetic polymorphisms which are associated with the susceptibility …

  • 0 views
  • 04 Mar, 2021
  • 1 location
Respiratory Virus Hospitalization Study (FLU 003 Plus)

. With the recognition that novel respiratory viruses other than novel influenza A viruses, e.g., Middle East Respiratory Syndrome Coronavirus (MERS-CoV), could become prevalent and of major public

respiratory tract infection
novel influenza a
  • 3440 views
  • 22 Apr, 2022
  • 59 locations
COPE - COVID-19 in Pregnancy and Early Childhood

the child in the long run are unknown. What is known is based on case-reports and small case-series solely. Both the coronaviruses causing Middle East Respiratory Syndrome (MERS) and Severe Acute

middle east respiratory syndrome
SARS
coronavirus infection
diabetes
covid-19
  • 22 views
  • 19 Jun, 2021
  • 27 locations
Qatar PREgnancy Covid-19 OUtcome Study (QPRECIOUS)

The in-utero exposure of acute viral infection in some instances is proven to have short- and long-term neonatal effects during the postnatal and childhood period and the Zika virus, measles, mumps, and rubella are few examples. COVID-19 is caused by a novel coronavirus strain of unknown consequences. The main purpose …

Accepts healthy volunteers
  • 0 views
  • 03 Jun, 2022
  • 1 location
Seroprevalence of SARS-Cov-2 Antibodies in Children

It is unknown what proportion of healthy children have been exposed to SARS-Cov-2 and how many have antibodies. The aim of this study is to follow a cohort of healthy children over six months and measure their antibodies to SARS-CoV-2.

Accepts healthy volunteers
antibody test
SARS
covid-19
  • 149 views
  • 22 Mar, 2022
  • 1 location